Marinnovac UK Limited (Formally JAS Biologicals Ltd) formed in 2004 by Susan Didlick and is one of the UK’s specialist veterinary vaccine development companies.  Their key staff, including the Managing Director Susan Didlick, have worked for Intervet UK Ltd a leading veterinary pharmaceutical company. Its core skills revolve around development of both live & inactivated viral antigens for commercially important animal & fish vaccines.

staff  has over 20 years experience in commercial veterinary vaccines. It has developed viral vaccines and virus-expressing cell lines for use by Veterinary Pharma Companies in the UK and overseas.

2019 changed the company name to Marinnovac UK Limited and in 2020 purchased Biosynergy Europe Limited a human antibody company. Marinnovac UK has over 20 fish viral & bacterial qPCR diagnostic assays and also validated ELISA assays and is able  to offer diagnostic testing and screening services for the industry. This technology development has assisted in Marinnovac UK  in being awarded the only VMD approved manufacturing viral AV license in the UK. The company employs 6 scientists all with an immunology, microbiology and cell culture backgrounds. Marinnovac UK is part of the Marinnovac Limited consortium based in Dublin in Ireland. Marinnovac limited are joint owners along with CZ Veterinaria (a vaccine GMP CMO compnay based in Spain) of the Spanish Aquaculture vaccine company "Aquatreck Animal Health S A."